-
myMDAnderson
Log in to our secure, personalized website to manage your care.
-
Request an Appointment
Request an Appointment
If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.
Appointment Information - Donate Today
- Departments, Labs and Institutes
- Research Centers and Programs
- Colorectal Cancer Translational Research Program
- Clinical Research Protocols
Clinical Research Protocols
A Phase III Randomized Double-Blind Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients with Refractory Advanced Colorectal Cancer (Perifosine 343)
Phase III, FOLFOX or FOLFIRI with Bevacizumab and/or Cetuximab in Patients with Untreated Metastatic Colorectal Cancer
Phase I/II Study of Azacitidine & CAPOX (Capecitabine + Oxaliplatin) in Metastatic CRC Pts Enriched for Hypermethylation of CpG Promoter Islands
Phase I Oral MK_2206 w/AZD6244 w/Locally Advanced or Metastatic Solid Tumors (Dose expansion phase is limited to patients in CRC, PANC & Melanoma Center)
FOLFOX + Cetuximab & Dasatinib in metastatic CRC (Ph II ONLY)
Phase II, Randomized, Double Blind Comparison of CASAD vs. Placebo for the Treatment and Prevention of Diarrhea in Patients with Metastatic Colorectal Cancer
Statin Polyp Prevention Trial in Patients with Resected Colon Cancer
Phase II Randomized Trial of SIR-Spheres, Yttruim Microspheres with Cetuximab Plus Irinotecan for Patients with Advanced Colorectal Cancer Metastases to the Liver
Phase III randomized controlled comparison of open versus laparoscopic total mesorectal excision for locally advanced rectal cancer following neoadjuvant chemoradiation
Biobehavioral Effects of Qigong During Rectal Cancer Treatment
Symptom Research Study: Prospective Study of Symptoms Related to Oxaliplatin-based Regimens in the Treatment of Colorectal Cancer
Multi-Institutional Colon/Rectal Cancer Outcomes Project Within NCCN
- Learn more about this clinical trial
A Phase I Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX4032 in Patients with Solid Tumors
Phase I Oral MK-2206 w/AZD6244 w/Locally Advanced or Metastatic Solid Tumors (Dose expansion phase is limited to patients in CRC, PANC & Melanoma Cancer)
Randomized, Phase III Study of Brivanib vs. Placebo as Adjuvant Therapy to Trans-Arterial Chemo-Embolization (TACE) in Patients with Unresectable HCC The BRISK TA study
A Phase III Trial of Irinotecan / 5-FU / Leucovorin or Oxaliplatin / 5-FU / Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum
Assessment of the Impact of Systemic Chemotherapy on the Quality of Life (QOL) in Patients with Metastatic Appendiceal Epithelial Neoplasms (AEN)
Multi-institutional colon/rectal cancer outcomes project within NCCN
- Learn more about this clinical trial
A Study To Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX4032 in Patients with Solid Tumors
A Phase I Study of Oral MK-2206 in Combination with Oral AZD6244 in Patients with Locally Advanced or Metastatic Solid Tumors (010-02)
A Randomized, Placebo-Controlled, Phase I/2 Study of ARQ 197 in Combination with Irinotecan and Cetuximab in Subjects with Metastatic Colorectal Cancer with Wild-Type KRAS Who Have Received Front-Line Systemic Therapy (ARQ 197-A-U252)
Phase II, Randomized, Double Blind Comparison of CASAD vs. Placebo for the Treatment and Prevention of Diarrhea in Patients with Metastatic Colorectal Cancer
Phase II Randomized study of SIR-Spheres, Yttrium microspheres with cetuximab plus irinotecan for patients with advanced colorectal cancer metastases to the liver